Mark Metersky, MD, FCCP, illustrates the pathology of bronchiectasis.
This is a video synopsis/summary of an Insights involving Mark Metersky, MD, FCCP, on bronchiectasis.
Bronchiectasis is an increasingly recognized pulmonary condition affecting approximately 400,000 people in the United States. The increased recognition is partly due to an aging population, as bronchiectasis commonly affects older patients, as well as increased diagnosis via chest CT scans. Clinically, bronchiectasis is characterized by chronic cough, usually with chronic daily sputum production, and often exacerbations causing worsened symptoms requiring antibiotics. It is diagnosed by CT scan identifying dilated, enlarged airways (bronchi). Some patients have bronchiectasis incidentally found on CT without significant symptoms, but most have chronic cough.
Exacerbations represent an acute worsening of symptoms like increased cough and sputum production or changes in sputum character, fever, chest pain, weakness, shortness of breath, and sometimes hemoptysis. Exacerbations can be from bacterial or viral causes, though the cause is often unidentified. Most exacerbations are treated with antibiotics.
Bronchiectasis demonstrates heterogeneous causes and manifestations without one typical presentation, though it predominantly affects older females. Symptoms vary widely, from minimal to significant impairment of quality of life with daily cough and copious sputum production, malaise, weakness, and shortness of breath in severe cases. Most patients do not have severe, debilitating disease leading to respiratory failure or death.
Video synopsis is AI-generated and reviewed by AJMCÒ editorial staff.
ATS 2024 Data Support Triple Therapy FF/UMEC/VI as Preferred Option for COPD
May 21st 2024New data reveal that starting furoate/umeclidinium/vilanterol (FF/UMEC/VI) without delay not only significantly reduces exacerbations and health care costs but also enhances adherence and persistence for patients with chronic obstructive pulmonary disease (COPD) compared with other therapies.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Unique Case: HCC With No Cirrhosis—and “Hidden” CLL/SLL
May 21st 2024A 77-year-old man had no risk factors for hepatocellular carcinoma (HCC), but he was nonetheless found to have it. Along the way, he was also diagnosed with previously undetected chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
Read More
Exploring Critical Advances in ARDS, Asthma, Lung Cancer, Health Equity at ATS 2024
May 20th 2024During a session at the American Thoracic Society (ATS) 2024 International Conference, experts presented the most impactful data from the last year on acute respiratory distress syndrome (ARDS), childhood asthma, health equity, and lung cancer.
Read More
Patients With COPD, PRISm at Increased All-Cause, Cause-Specific Mortality Risk
May 20th 2024Patients with chronic obstructive pulmonary disease (COPD) and/or preserved ratio impaired spirometry (PRISm) have an increased risk of all-cause and cause-specific mortality, highlighting the need for better understanding of these conditions through increased spirometry data collection.
Read More